TapewireFind a company

person · Reporting owner

Wong Shelly

Disclosed activity across 1 company

Tapewire entity
22279
SEC CIK
0001857740

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ALX ONCOLOGY HOLDINGS INCALXO · Entity 6040SVP, FINANCE AND CAOAugust 17, 2026August 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ALX ONCOLOGY HOLDINGS INC

Report date August 17, 2026 · Filed August 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect87,828 Reported balance After 2026-08-17 transaction · row 1
1 source row

Row 1 · 2026-08-17 · Sale · Disposed 573 · Balance 87,828

F1: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2026 Filed Aug 18, 2026 21:50 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 573 $1.93 $1,105.89
Disclosure

SEC source: 0001193125-26-355761 · ownership.xml · nonDerivative · entry 1

Wong Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,828

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:30 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 1,404 $2.04 $2,864.16
Disclosure

SEC source: 0001193125-26-296246 · ownership.xml · nonDerivative · entry 1

Wong Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,401

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 20:05 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 903 $2.17 $1,959.51
Disclosure

SEC source: 0001193125-26-119703 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,805

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of perfomance-based restricted stock units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 21:01 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 565 $2.27 $1,282.55
Disclosure

SEC source: 0001193125-26-061313 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,708

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 21:30 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantStock option (right to buy) · Derivative 192,000 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001193125-26-027288 · ownership.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,000

Underlying: Common Stock · 192,000 shares

Expires 2036-01-25

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026.

Read SEC document
January 06, 2026 Filed Jan 7, 2026 21:30 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 3,925 $1.11 $4,356.75
Disclosure

SEC source: 0001193125-26-006374 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,273

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2025.

Read SEC document
October 14, 2025 Filed Oct 16, 2025 20:01 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 140,000 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001193125-25-241382 · ownership.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2035-10-14

F1 · derivative.exercise_date: One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:12 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 611 $0.64 $391.28
Disclosure

SEC source: 0000950170-25-110102 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,198

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2025.

Read SEC document
July 07, 2025 Filed Jul 8, 2025 20:37 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 2,011 $0.45 $905.15
Disclosure

SEC source: 0000950170-25-094613 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,809

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.45 to $0.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
June 30, 2025 Filed Jul 1, 2025 20:22 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 1,532 $0.43 $658.76
Disclosure

SEC source: 0000950170-25-092232 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,820

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
April 11, 2025 Filed Apr 15, 2025 20:29 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 90,000 $0.00 Strike: $0.49 $0.00
Disclosure

SEC source: 0001415889-25-010697 · form4-04152025_080416.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2035-04-11

F1 · derivative.exercise_date: All of the shares subject to the option vest on April 11, 2026.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 20:45 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008428 · form4-03182025_080356.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,352

F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 21:25 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 550 $1.15 $632.61
Disclosure

SEC source: 0001415889-25-005071 · form4-02212025_090224.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,352

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:14 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 112,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001965 · form4-01232025_110113.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 21:10 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 2,221 $1.80 $3,997.80
Disclosure

SEC source: 0001415889-25-001120 · form4-01082025_090144.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,902

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 21:46 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 1,426 $1.58 $2,253.37
Disclosure

SEC source: 0001415889-25-000132 · form4-01022025_090133.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,123

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:15 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $1.66 $0.00
Disclosure

SEC source: 0001415889-24-028245 · form4-12042024_091224.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2031-12-01

F1 · derivative.exercise_date: Shares subject to the option vest in 30 equal monthly installments beginning on January 2, 2025.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 21:10 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 564 $2.58 $1,455.12
Disclosure

SEC source: 0001415889-24-021482 · form4-08162024_090836.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,549

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
July 05, 2024 Filed Jul 9, 2024 20:09 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 1,823 $5.50 $10,025.22
Disclosure

SEC source: 0001415889-24-019429 · form4-07092024_080737.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,113

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 21:03 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 1,373 $5.82 $7,989.21
Disclosure

SEC source: 0001415889-24-019228 · form4-07032024_090722.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,936

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.77 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 23:24 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 35,000 $0.00 Strike: $15.84 $0.00
Disclosure

SEC source: 0001415889-24-004233 · form4-02162024_110202.xml · derivative · entry 2

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2034-02-13

F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 23:24 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-004233 · form4-02162024_110202.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,591

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 21:03 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 2,717 $13.60 $36,956.63
Disclosure

SEC source: 0001209191-24-000985 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,591

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.59 to $13.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:28 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 1,631 $15.04 $24,530.24
Disclosure

SEC source: 0001209191-24-000379 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,308

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · balance_after: Includes 1,226 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023.

Read SEC document
July 25, 2023 Filed Jul 27, 2023 20:19 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 36,000 $0.00 Strike: $5.86 $0.00
Disclosure

SEC source: 0001209191-23-043523 · doc4.xml · derivative · entry 2

Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2033-07-24

F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023.

Read SEC document
July 25, 2023 Filed Jul 27, 2023 20:19 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantCommon Stock 26,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-043523 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, Finance and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,713

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023.

Read SEC document
July 06, 2023 Filed Jul 7, 2023 20:09 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 7,345 $6.52 $47,889.40
Disclosure

SEC source: 0001209191-23-041790 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,713

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 21:05 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 466 $7.34 $3,420.44
Disclosure

SEC source: 0001209191-23-041189 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,058

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · balance_after: Includes 1,427 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023.

Read SEC document
December 29, 2022 Filed Jan 4, 2023 01:52 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 SaleCommon Stock 482 $11.07 $5,335.69
Disclosure

SEC source: 0001209191-23-000485 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,097

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.04 to $11.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects a reduction of 139 shares previously reported as acquired pursuant to the Issuer's employee stock purchase plan on June 30, 2022.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 22:07 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 36,000 $0.00 Strike: $11.47 $0.00
Disclosure

SEC source: 0001209191-22-045064 · doc4.xml · derivative · entry 2

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2032-08-04

F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 22:07 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-045064 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,718

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022.

F2 · balance_after: Includes 1,272 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 21:36 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005923 · doc4.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,446

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest as follows: three-eighths of the RSUs vest on July 3, 2023 and the remaining RSUs vest thereafter in five equal semiannual installments.

F2 · balance_after: Includes 446 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021.

Read SEC document
July 30, 2021 Filed Aug 3, 2021 21:28 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 25,000 $0.00 Strike: $58.56 $0.00
Disclosure

SEC source: 0001209191-21-049415 · doc4.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-07-29

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 30, 2021.

Read SEC document
May 03, 2021 Filed May 19, 2021 21:26 UTC Amendment ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $62.83 $0.00
Disclosure

SEC source: 0001209191-21-034072 · doc4a.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2031-05-03

F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on May 3, 2022 and 1/48th of the shares vest monthly thereafter.

Read SEC document
May 03, 2020 Filed May 5, 2021 20:29 UTC ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 GrantEmployee Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $62.83 $0.00
Disclosure

SEC source: 0001209191-21-030336 · doc4.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · VP, Finance and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2030-05-03

F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on May 3, 2022 and 1/48th of the shares vest monthly thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.